Stock in News: Facebook Inc (NASDAQ FB) Monthly Users Equal China’s Population
Facebook Inc (NASDAQ FB) stock spiked in early trading on Monday following a report from Morgan Stanley which initiated coverage assigning an Overweight rating and a price target of $90 on the stock. Morgan Stanley’s Benjamin Swinburne also tells investors not to worry about the rising expenses. Facebook’s increasing expenses will hurt the stock in the short term, but the firm remains a solid long-term … Continue reading Stock in News: Facebook Inc (NASDAQ FB) Monthly Users Equal China’s Population
Today’s Hot List: The Charles Schwab Corporation (NYSE:SCHW), Taiwan Semiconductor, Chesapeake Granite Wash Trust (NYSE:CHKR), Lakeland Industries Inc. (NASDAQ:LAKE), Harley-Davidson, Inc. (NYSE:HOG)
The Charles Schwab Corporation (NYSE:SCHW) is continuing to fight back against former brokers who leave its ranks. In one of its most recent actions, the firm filed suit last month against a Tampa, Fla.-based registered investment adviser, Camelot Wealth Management. Schwab accused the RIA, which was founded earlier this year by former Schwab branch manager Brian Mahoney, of engaging in a “civil conspiracy” when it … Continue reading Today’s Hot List: The Charles Schwab Corporation (NYSE:SCHW), Taiwan Semiconductor, Chesapeake Granite Wash Trust (NYSE:CHKR), Lakeland Industries Inc. (NASDAQ:LAKE), Harley-Davidson, Inc. (NYSE:HOG)
Traders Are Watching: Morgan Stanley (NYSE:MS), HomeAway, Inc. (NASDAQ:AWAY), Unilife Corporation (NASDAQ:UNIS), Telefonica Brasil, S.A. (NYSE:VIV), Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)
“A common thread in our discussions (with supermarket industry leaders) has been declining Woolworths in-store execution,” said Morgan Stanley (NYSE:MS) analyst Tom Kierath. “Rising out of stocks, declining fresh food displays and tired stores were comments of note,” said Mr Kierath, who has cut his share price target from $31 to $30 and reduced his net profit forecast from $2.55 billion to $2.53 billion. Analysts … Continue reading Traders Are Watching: Morgan Stanley (NYSE:MS), HomeAway, Inc. (NASDAQ:AWAY), Unilife Corporation (NASDAQ:UNIS), Telefonica Brasil, S.A. (NYSE:VIV), Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)
Stocks to Watch: Exxon Mobil Corporation (NYSE:XOM), InvenSense, Inc. (NYSE:INVN), Identiv, Inc. (NASDAQ:INVE), Atlas Resource Partners, L.P. (NYSE:ARP), Haverty Furniture Companies Inc. (NYSE:HVT)
Exxon Mobil (NYSE:XOM) last issued its quarterly earnings data on Friday, October 31st. The company reported $1.89 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.73 by $0.16. The company had revenue of $107.50 million for the quarter, compared to the consensus estimate of $105.50 billion. During the same quarter last year, the company posted $1.79 earnings per share. Exxon Mobil’s … Continue reading Stocks to Watch: Exxon Mobil Corporation (NYSE:XOM), InvenSense, Inc. (NYSE:INVN), Identiv, Inc. (NASDAQ:INVE), Atlas Resource Partners, L.P. (NYSE:ARP), Haverty Furniture Companies Inc. (NYSE:HVT)
Worth Watching Stocks: Alpha Natural Resources, Inc. (NYSE:ANR), Kinross Gold Corporation (NYSE:KGC), Palo Alto Networks, Inc. (NYSE:PANW), Norfolk Southern Corporation (NYSE:NSC), FNHC
Alpha Natural Resources, Inc. (NYSE:ANR) on Oct. 30 said its third-quarter loss narrowed, helped by reduced costs. The coal producer’s performance topped analysts’ estimates. ANR lost $185 million, or 84 cents per share, for the three months ended Sept. 30. That compares with a loss of $458.2 million, or $2.07 per share, a year ago. Stripping out certain items, it lost 53 cents per share. … Continue reading Worth Watching Stocks: Alpha Natural Resources, Inc. (NYSE:ANR), Kinross Gold Corporation (NYSE:KGC), Palo Alto Networks, Inc. (NYSE:PANW), Norfolk Southern Corporation (NYSE:NSC), FNHC
Moving Stocks: Geron Corporation (NASDAQ:GERN), Alcatel Lucent SA (ADR) (NYSE:ALU), CenterState Banks, Inc. (NASDAQ:CSFL), Highpower International, Inc. (NASDAQ:HPJ), Ensco plc (NYSE:ESV)
Geron Corp (NASDAQ:GERN) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $160 thousand versus the consensus estimate of $240 thousand. The company also announced that the U.S. Food and Drug Administration (FDA) has removed the full clinical hold on Geron’s investigational new drug (IND) application for imetelstat. In addition, the FDA stated that Geron’s … Continue reading Moving Stocks: Geron Corporation (NASDAQ:GERN), Alcatel Lucent SA (ADR) (NYSE:ALU), CenterState Banks, Inc. (NASDAQ:CSFL), Highpower International, Inc. (NASDAQ:HPJ), Ensco plc (NYSE:ESV)
